Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer diseasePatrick G. Kehoe, Michael J. Owen, Carsten Russ et al.|Nature Genetics|1999Cited by 262
Designing drug trials for Alzheimer's disease: What we have learned from the release of the phase III antibody trials: A report from the EU/US/CTAD Task ForceBruno Vellas, H. Robert Brashear, Eric Siemers et al.|Alzheimer s & Dementia|2013Cited by 145